A - Agilent Technologies, Inc.
| Previous Close | 88.68 |
| Open | 89.02 |
| Bid | 88.79 x 3100 |
| Ask | 89.32 x 1800 |
| Day's Range | 89.02 - 90.58 |
| 52 Week Range | 61.13 - 93.04 |
| Volume | 1,219,585 |
| Avg. Volume | 2,031,327 |
| Market Cap | 27.577B |
| Beta (5Y Monthly) | 1.12 |
| PE Ratio (TTM) | 40.99 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.72 (0.81%) |
| Ex-Dividend Date | Jun. 29, 2020 |
| 1y Target Est | N/A |
- Business Wire
Agilent Technologies Announces Pricing of $500 Million of Senior Notes
Agilent announces pricing of $500 million of senior notes.
- Business Wire
Agilent Technologies Announces Proposed Offering of Senior Notes
Agilent announces proposed offering of senior notes.
- Business Wire
Agilent Announces New Mass Spectrometry Products at ASMS 2020 Reboot
Agilent Technologies Inc. (NYSE: A) today announced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system. Both deliver even faster detection of target compounds providing customers increased sample throughput and reduced time to generate results. The instruments are being introduced at ASMS 2020 Reboot, the interactive, online version of the annual conference of the American Society for Mass Spectrometry, being held June 1-12, 2020.
- Business Wire
Agilent to Present at Jefferies Virtual Healthcare Conference
Agilent to present at Jefferies Virtual Healthcare Conference.
- Business Wire
Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results
Agilent announces second quarter earnings.
- Business Wire
Agilent Announces Cash Dividend of 18 Cents Per Share
Agilent announces dividend of 18 cents per share.
- Business Wire
Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral
Agilent Technologies Inc. (NYSE: A) announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge, Massachusetts. LabCentral is a shared laboratory space designed as a launchpad for high-potential life sciences and biotech startups. The Golden Ticket provides funding of one lab bench space for a year.
- Business Wire
Agilent Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 22C3 pharmDx as a companion diagnostic (CDx) to identify patients with non-small cell lung cancer who are appropriate for first-line monotherapy with KEYTRUDA (pembrolizumab) on the Dako Omnis platform.
- Business Wire
Agilent Signs Sponsorship Agreement with My Green Lab
Agilent Technologies Inc. (NYSE: A) announced today that it has become a top-level sponsor of My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research.
- Business Wire
Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21
Agilent provides update on COVID-19 impact and sets second-quarter earnings call for May 21.
- Business Wire
Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers
Agilent Technologies Inc. (NYSE: A) today announced the launch of the newest instrument in its Raman technology portfolio. The new Agilent Vaya Raman raw material identity verification system is a handheld instrument that accelerates quality control testing in the pharmaceutical and biopharmaceutical industries.
- Business Wire
Agilent Technologies to Change Location of Annual Meeting
Agilent to host annual shareholder meeting online.
- Business Wire
Agilent Announces New Class 1 Triple Quadrupole LC/MS System
Agilent Technologies Inc. (NYSE: A) today introduced the Agilent K6460S Clinical Edition TQ LC/MS system, designed to improve in vitro diagnostic workflows in clinical labs.
- Business Wire
Agilent Technologies Announces Cash Dividend of 18 Cents Per Share
Agilent announces cash dividend of 18 cents per share.
- Business Wire
Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020
Agilent adjourns annual shareholder meeting to April 17.
- Business Wire
Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring
Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for laboratories seeking increased visibility and control over operations.
- Business Wire
Agilent Receives Two Scientists’ Choice Awards
Agilent Technologies Inc. (NYSE: A) today announced that two of the company’s instruments have received Scientists’ Choice awards. The Agilent 8890 GC system won for Best New Separations Product, and the Agilent InfinityLab LC/MSD iQ system won for Best New Spectroscopy Product.
- Business Wire
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.
- Business Wire
Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions
Agilent Technologies Inc. (NYSE: A) and Visiopharm today announced that they have entered a co-marketing agreement. The announcement is happening at the USCAP 109th Annual Meeting being held February 29 through March 5, 2020, in Los Angeles, CA.
